Compare Suncare Traders with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with a -7.87% CAGR growth in Net Sales over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1.12
- The company has been able to generate a Return on Equity (avg) of 1.86% signifying low profitability per unit of shareholders funds
Flat results in Dec 25
Risky - Negative EBITDA
Total Returns (Price + Dividend) 
Suncare Traders for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Suncare Traders Ltd Stock Falls to 52-Week Low of Rs.0.54
Suncare Traders Ltd, a micro-cap company in the Trading & Distributors sector, has touched a new 52-week low of Rs.0.54 today, marking a significant decline in its stock price amid broader market pressures and company-specific factors.
Read full news article
Suncare Traders Ltd Falls to 52-Week Low Amidst Weak Financial Metrics
Suncare Traders Ltd, a company operating in the Trading & Distributors sector, recorded a new 52-week low of Rs.0.57 today, marking a significant decline in its stock price. This drop comes after a brief two-day rally and reflects ongoing challenges in the company’s financial and market performance.
Read full news article
Suncare Traders Ltd Falls to 52-Week Low Amidst Weak Financial Metrics
Suncare Traders Ltd has touched a new 52-week low of Rs.0.6 today, marking a significant decline in its stock price amid ongoing concerns over its financial performance and valuation metrics. This drop contrasts sharply with the broader market trend, where the Sensex continues to climb towards its 52-week high.
Read full news article Announcements 
Board Meeting Outcome for Outcome Of The Board Meeting Of The Board Held On 3Rd February 2026.
03-Feb-2026 | Source : BSEPursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company in their meeting held on today i.e. Tuesday 3rd February 2026 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter and nine months ended as on 31st December 2025. The board meeting commenced at 03:00 PM and concluded at 03:30 PM Please take the above intimation in your records. Thanking You.
Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015
03-Feb-2026 | Source : BSEPFA
Regulations 30 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
03-Feb-2026 | Source : BSEPFA
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
Suncare Traders Ltd has announced 2:10 stock split, ex-date: 06 Mar 20
Suncare Traders Ltd has announced 2:1 bonus issue, ex-date: 06 Mar 20
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
Biogen Pharmachem Industries Limited (4.29%)
Shah Enterjrise (11.76%)
65.32%
Quarterly Results Snapshot (Standalone) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is 0.00% vs -100.00% in Dec 2024
YoY Growth in quarter ended Dec 2025 is -63.16% vs 480.00% in Dec 2024
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is -633.33% vs 108.33% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 0.00% vs -100.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -84.81% vs 241.07% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -100.00% vs -99.34% in Mar 2024
YoY Growth in year ended Mar 2025 is 51.28% vs 102.11% in Mar 2024






